| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.9 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |